Context Therapeutics
CNTX
#10163
Rank
A$76.97 M
Marketcap
A$0.84
Share price
-6.07%
Change (1 day)
-35.70%
Change (1 year)

Earnings for Context Therapeutics (CNTX)

Earnings in 2026 (TTM): -A$60.08 Million

According to Context Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$51.77 Million a decrease over its 2024 earnings that were of -A$38.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Context Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$60.08 Million16.05%
2025 -A$51.77 Million35.17%
2024 -A$38.3 Million11.52%
2023 -A$34.35 Million61.53%
2022 -A$21.26 Million41.88%
2021 -A$14.99 Million-257.38%
2020 A$9.52 M